Dr Yesha / Prof Yesha

17-Mar-2024: Teva BioMix 2024 Opens & 2023 Competition

On 17-Mar-2024 the National Bioinnovators Forum gathered for the annual event at Teva’s innovative R&D site ABIC, Netanya.

During the last few years, more than 30 research collaborations have been initiated with Israeli labs to develop new therapeutics and theologies.

In addition to celebrating the strong collaborative relationships with the ecosystem, the National BioInnovators student forum was officially opened for the 2024 cohort, as well as marking the graduation of the 2023 cohort, with over 150 members.

The most exciting part was the 2023 BioMix competition, presenting the 5 finalists’ ventures.

The professional jury included: Prof. Ronit Satchi-Fainaro, Prof. Varda Shalev, Dr. Eran Harary, Dr. Yael Pomerantz, and Dr. Nadav Klein, Ph.D. Their insightful feedback and advice are much appreciated. Dr. Tal Tova Patalon, MD, gave the keynote talk.

The winners of the BioMix 2023 competition:
ImplanTech by Noy Pinto and team. Won audience favorite as well;
EndoEase by Dr. Ela Bar and her team.

The BioInnovatos program is led by Dr. Dana Bar-On, Head of Academic Affairs and Networks, Global R&D at Teva Pharmaceuticals, and partnering with Prof. Yesha Sivan, Founder and CEO at DigitalRosh, the 2023 mentors, and the Teva mentors who support the program.

Exit mobile version